Addex Therapeutics Ltd ADXN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 949.70K | 1.17M | 2.07M | 2.74M | 3.20M |
| Total Receivables | 36.80K | 39.90K | 25.30K | 64.30K | 40.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 293.90K | 274.50K | 20.60K | 149.80K | 372.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.90K | 2.90K | 6.50K | 8.60K | 7.70K |
| Total Current Assets | 1.29M | 1.48M | 2.12M | 2.97M | 3.62M |
|
|
|||||
| Total Current Assets | 1.29M | 1.48M | 2.12M | 2.97M | 3.62M |
| Net Property, Plant & Equipment | 94.30K | 126.50K | 43.20K | 45.60K | 45.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 697.50K | 702.70K | 650.90K | 647.30K | 8.00K |
| Total Assets | 4.31M | 5.93M | 8.03M | 9.19M | 10.73M |
|
|
|||||
| Total Accounts Payable | 960.40K | 788.90K | 760.30K | 509.30K | 323.70K |
| Total Accrued Expenses | 602.60K | 579.30K | 742.00K | 954.60K | 749.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 67.40K | 96.30K | 9.70K | 9.50K | 8.40K |
| Total Finance Division Other Current Liabilities | 58.70K | 59.20K | -- | -- | 114.50K |
| Total Other Current Liabilities | 58.70K | 59.20K | -- | -- | 114.50K |
| Total Current Liabilities | 1.69M | 1.52M | 1.51M | 1.47M | 1.20M |
|
|
|||||
| Total Current Liabilities | 1.69M | 1.52M | 1.51M | 1.47M | 1.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.50K | 31.20K | 34.10K | 36.30K | 37.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 228.80K | 280.90K | 468.60K | 211.20K | 112.40K |
| Total Liabilities | 1.95M | 1.84M | 2.01M | 1.72M | 1.35M |
|
|
|||||
| Common Stock & APIC | 333.92M | 336.05M | 339.86M | 337.47M | 303.44M |
| Retained Earnings | -449.93M | -451.06M | -454.12M | -449.29M | -401.42M |
| Treasury Stock & Other | 118.38M | 119.11M | 120.26M | 119.29M | 107.36M |
| Total Common Equity | 2.36M | 4.10M | 6.01M | 7.47M | 9.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.36M | 4.10M | 6.01M | 7.47M | 9.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.36M | 4.10M | 6.01M | 7.47M | 9.38M |
|
|
|||||